Clinical Trial Update: Pilot Efficacy Study of T2000 in Myoclonus Dystonia [Phase 2]

View source ↗

Summary

A Phase 2 pilot efficacy study of T2000 for myoclonus-dystonia was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myoclonus-dystonia

Drugs mentioned

• T2000

Snippet

Sponsor: Sun Pharmaceutical Industries, Inc. | Conditions: Myoclonus | Phase 2 | Status: TERMINATED